Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AL-78898A in Geographic Atrophy
NCT01603043Phase 2Terminated
- Sponsor
- Alcon Inc.
- Start
- Jun 2012
- Primary completion
- Nov 2012
- Modality
- Small Molecules, Cyclic Peptides
01
Overview
A Phase 2 trial of AL-78898A in geographic atrophy (GA), sponsored by Alcon Inc.. Started Jun 2012; status: terminated.
02
Drugs
AL-78898A
03
Conditions
geographic atrophy (GA)
Beyond the preview
Go deeper on NCT01603043.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01603043.